Description

Each Owens Peptide Solutions vial contains 10mg of lyophilized Tesamorelin for qualified laboratory investigation. Tesamorelin is modeled on the complete 44-amino-acid sequence of human growth hormone-releasing factor and includes an N-terminal hexenoyl modification designed to alter peptide stability.

Research Use Disclaimer:

For laboratory and research use only. Not intended for human or animal consumption, medical use, diagnostic use, veterinary use, or therapeutic application.

In experimental systems, Tesamorelin interacts with growth hormone-releasing factor receptors associated with pituitary somatotroph signaling. Research has examined its relationship with pulsatile growth hormone release, downstream IGF-1 activity, receptor pharmacology, and hypothalamic-pituitary signaling.

Study outcomes depend on the selected model, concentration, preparation method, and analytical conditions. They should not be interpreted as directions or authorization for medical or consumer use.